Blood cancer Clinical Trials in Milwaukee, WI
As of June 2026, 68 paid clinical trials are recruiting for Blood cancer in Milwaukee, Wisconsin. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
68 clinical trials for Blood cancer
·Clear filters·↓ Download CSVFT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
About research studies in Milwaukee
Milwaukee has approximately 711 recruiting research studies across a wide range of therapeutic areas. Wisconsin hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Milwaukee
Researchers run research studies in Milwaukee, WI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Medical College of Wisconsin | Acute Myeloid Leukemia, Stroke, Chronic Lymphocytic Leukemia | 266 |
| Aurora Sinai Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 52 |
| Aurora Saint Luke's Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 51 |
| Aurora Cancer Care-Milwaukee | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 47 |
| Children's Hospital of Wisconsin | B Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Malignant Solid Neoplasm | 44 |
| Froedtert & the Medical College of Wisconsin | Pancreatic Cancer, Refractory Multiple Myeloma, Relapse Multiple Myeloma | 20 |
| Froedtert Hospital & the Medical College of Wisconsin | Breast Cancer, Pancreas Cancer, AL Amyloidosis | 20 |
| Children's Wisconsin | Abdominal Pain, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Refractory | 19 |
| Froedtert Hospital | Aortic Stenosis, Atrial Fibrillation, Bladder Cancer | 19 |
| Aurora St. Luke's Medical Center | Pulmonary Hypertension, Acute Decompensated Heart Failure, Acute Ischemic Stroke From Large Vessel Occlusion | 16 |
| Froedtert Hospital and the Medical College of Wisconsin | B-cell Lymphoma, Breast Cancer, Cancer | 16 |
| Ascension Columbia Saint Mary's Hospital - Milwaukee | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 15 |
| The Medical College of Wisconsin | Abdominal Wound Dehiscence, Acute Kidney Injury, Anal Fistula | 14 |
| Ascension Southeast Wisconsin Hospital - Saint Joseph Campus | Malignant Solid Neoplasm, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | 9 |
| Froedtert & Medical College of Wisconsin | Cystic Fibrosis (CF), Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML) | 9 |
| Marquette University | Stroke, Aging, Aerobic Exercise | 9 |
| Zablocki Veterans Administration Medical Center | Chronic Lymphocytic Leukemia, Stage IVA Prostate Cancer AJCC v8, Acute Lymphoblastic Leukemia | 9 |
| Ascension Saint Francis Hospital | Malignant Solid Neoplasm, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | 8 |
| Froedtert and The Medical College of Wisconsin | Adenocarcinoma, Bronchiectasis, Epithelial Ovarian Cancer | 6 |
| Aurora St Luke's Medical Center | AMI, Cancer, Cutaneous Melanoma, Stage II | 5 |
| Clement J. Zablocki VA Medical Center, Milwaukee, WI | Atherosclerosis, De Novo Prostate Cancer, Lung Neoplasm | 4 |
| Medical College of Wisconsin/Children's Hospital of Wisconsin | Primary Immune Deficiency Disorder, Adenovirus, Covid19 | 4 |
| Advocate Aurora Research Institute | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 3 |
| Aurora St. Luke's Medi Ctr | Heart Failure, Acute Myocardial Infarction (AMI), Cardiovascular Risk | 3 |
| Children's Hospital Wisconsin | Congenital Heart Disease, Deep Venous Thrombosis, Duchenne Muscular Dystrophy | 3 |
Active & Upcoming Studies in Milwaukee (2026)
Recruiting trials in Milwaukee grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (283 active studies)
- Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies · Phase 1 · Medical College of Wisconsin
- Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors · Phase 2 · Medical College of Wisconsin
Cardiovascular (51 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Peripheral Venous Pressure (PVP) Trial · Wake Forest University Health Sciences
Neurology & pain (37 active studies)
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
Diabetes & metabolic (22 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Puerto Rican Obesity Intervention for Men · Medical College of Wisconsin
Pediatric (12 active studies)
- Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers · Medical College of Wisconsin
- Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure · Medical College of Wisconsin
Mental health & behavior (5 active studies)
- My Path to Quit Tobacco · Phase 4 · University of Wisconsin, Madison
- Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers · Marquette University
HIV / STI (4 active studies)
- Screen Smart: Using Digital Health to Improve HIV Screening and Prevention · Children's Hospital Medical Center, Cincinnati
- A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 · Phase 3 · ViiV Healthcare
Vaccines (3 active studies)
Eye & vision (2 active studies)
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy · Astellas Pharma Global Development, Inc.
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease · Phase 2 · Alkeus Pharmaceuticals, Inc.
Common conditions studied in Milwaukee
- Heart Failure (16 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Acute Myeloid Leukemia (15 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (14 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Follicular Lymphoma (11 active studies). Lymphoma research explores bispecific antibodies, CAR-T cell therapies, and new targeted agents for Hodgkin and non-Hodgkin lymphomas.
- Prostate Cancer (10 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Stroke (10 active studies). Stroke trials test acute reperfusion strategies, neuroprotective agents, and rehabilitation technologies to improve recovery.
Leading research sponsors in Milwaukee
- Medical College of Wisconsin
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- NRG Oncology
Local regulations and guidelines
Clinical trials in Wisconsin are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Wisconsin research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Milwaukee. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Milwaukee
Hipa.ai aggregates every recruiting study in Milwaukee from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Milwaukee?
There are approximately 711 recruiting clinical trials in Milwaukee, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Milwaukee pay participants?
Most recruiting trials in Milwaukee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Milwaukee?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Milwaukee?
The most common conditions under active study in Milwaukee include Heart Failure (16), Acute Myeloid Leukemia (15), Breast Cancer (14), Follicular Lymphoma (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Milwaukee?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milwaukee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Milwaukee?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Milwaukee?
Recruiting research sites in Milwaukee include Medical College of Wisconsin, Aurora Sinai Medical Center, Aurora Saint Luke's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Milwaukee right now?
The largest active categories in Milwaukee are Cancer & tumors (283), Cardiovascular (51), Neurology & pain (37). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.